Ahmet Dirican: Can Intermuscular Fat Predict Immunotherapy Response?
Ahmet Dirican/X

Ahmet Dirican: Can Intermuscular Fat Predict Immunotherapy Response?

Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:

“Can intermuscular fat predict immunotherapy response?

AI-driven analysis in 2,132 NSCLC patients:

92 body composition parameters extracted from CT and integrated with RNA-seq data.

Findings:

  • Intermuscular fat (IMFV) – better OS

High IMFV associated with:

  • T-cell exhaustion.
  • Interferon signaling.
  • Immune activation.

Discussion:

Fat is not just storage – it may actively shape anti-tumor immunity.

BMI is not enough. Body composition matters.

This study raises the idea that resistance and endurance exercise may influence immunotherapy response.”

Title: AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study

Authors: Yusheng Guo, Bingxin Gong, Jie Lou, Li Wan, Ying-Long Peng, Yiqun Chen, Xiaoyan Lei, Peng Mo, Qi Wan, Qing Sun, Shu Peng, Chuansheng Zheng, Lian Yang

Read The Full Article

Ahmet Dirican

Other articles about Immunotherapy on OncoDaily.